← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2021Last known activity
Aug 10, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (8)
- NCT06019117Study directorN/AAug 10, 2023
- NCT05671796OfficialPhase 2Apr 1, 2023
- NCT05671796Lead sponsorPhase 2Apr 1, 2023
- NCT05671796Study directorPhase 2Apr 1, 2023
- NCT05542693CollaboratorPhase 2Jan 31, 2023
- NCT04844268Lead sponsorPhase 1Oct 31, 2021
- NCT05446961Lead sponsorPhase 2Mar 1, 2021
- NCT05446961Overall official - principal investigatorPhase 2Mar 1, 2021
Details
- Last known activity
- Aug 10, 2023